Filter News
Area of Research
- (-) Neutron Science (3)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (1)
- Clean Energy (5)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (3)
- Materials (9)
- Materials for Computing (1)
- National Security (3)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (3)
- (-) Computer Science (2)
- (-) Isotopes (1)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (1)
- Bioenergy (1)
- Biology (1)
- Composites (1)
- Coronavirus (1)
- Environment (1)
- Fusion (1)
- Materials (1)
- Materials Science (3)
- Nanotechnology (1)
- Neutron Science (14)
- Nuclear Energy (2)
- Physics (3)
- Quantum Science (1)
Media Contacts
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.